Website stats for Allakos - allakos.com
Developing therapeutic antibodies targeting allergic, inflammatory, and proliferative diseases
allakos.com was registered 1 decade 2 years ago. It has a alexa rank of #2,037,816 in the world. It is a domain having .com extension. It is estimated worth of $ 720.00 and have a daily income of around $ 3.00. As no active threats were reported recently, allakos.com is SAFE to browse.
Traffic Report
| Daily Unique Visitors: | 430 |
| Daily Pageviews: | 860 |
Estimated Valuation
| Income Per Day: | $ 3.00 |
| Estimated Worth: | $ 720.00 |
Search Engine Indexes
| Google Indexed Pages: | Not Applicable |
| Yahoo Indexed Pages: | Not Applicable |
| Bing Indexed Pages: | Not Applicable |
Search Engine Backlinks
| Google Backlinks: | Not Applicable |
| Bing Backlinks: | Not Applicable |
| Alexa BackLinks: | Not Applicable |
Safety Information
| Google Safe Browsing: | No Risk Issues |
| Siteadvisor Rating: | Not Applicable |
| WOT Trustworthiness: |
 Very Poor
|
| WOT Privacy: |
Very Poor
|
| WOT Child Safety: |
Very Poor
|
Website Ranks & Scores
| Alexa Rank: | 2,037,816 |
| PageSpeed Score: | 80 ON 100 |
| Domain Authority: |
49 ON 100 
|
| Bounce Rate: | Not Applicable |
| Time On Site: | Not Applicable |
Web Server Information
Hosted IP Address:
69.63.140.80
Hosted Country:
US
Location Latitude:
32.7831Location Longitude:
-96.8067Traffic Classification
| Total Traffic: | No Data |
| Direct Traffic: | 53.83% |
| Referral Traffic: | 4.16% |
| Search Traffic: | 42.00% |
| Social Traffic: | 0% |
| Mail Traffic: | 0% |
| Display Traffic: | 0% |
Search Engine Results For allakos.com
Allakos | AK002 mAb | Eosinophilic Gastroenteritis
Allakos is developing therapeutic antibodies that selectively target eosinophils and mast cells, cells that play a significant role in many diseases
Allakos Inc | LinkedIn
Allakos Inc | 1,704 followers on LinkedIn. Allakos Inc. is a publicly traded clinical-stage biopharmaceutical company developing first-in-class antibody-based therapeutics to...
Allakos - Crunchbase Company Profile & Funding
Contact Email [email protected] Phone Number (650)597-5002 Allakos develops antibody-based therapeutics to treat diseases in which dysregulation of the T-helper type 2 immune...
Allakos Inc - Biocom
Allakos is a clinical stage biotechnology company developing antibodies that target immunomodulatory receptors present on immune effector cells involved in allergic,...
Allakos Inc. (ALLK) Stock Price, News, Quote & History ...
For more information, please visit the Company's website at www.allakos.com.Forward-Looking StatementsThis press release contains forward-looking statements within the meaning...
ALLK - Allakos Inc Stock quote - CNNMoney.com
Find real-time ALLK - Allakos Inc stock quotes, company profile, news and forecasts from CNN Business.
ALLK Stock Forecast, Price & News (Allakos) | MarketBeat
The official website for Allakos is www.allakos.com. How can I contact Allakos? Allakos' mailing address is 975 ISLAND DRIVE SUITE 201, REDWOOD CITY CA, 94065. The company can...
ALLK.O - Allakos Inc Profile | Reuters
Allakos, Inc. is a clinical-stage biotechnology company, which is engaged in developing antibodies that selectively target mast cells and eosinophils. The Company's antibodies...
Allakos Inc (ALLK) Quote | Morningstar
Business Description. Allakos Inc is a clinical-stage company developing therapeutic antibodies that selectively target immunomodulatory receptors present on the surface of...
Allakos Announces a Presentation of Antolimab in Patients ...
May 11, 2020 · For more information, please visit the Company's website at www.allakos.com. Source: Allakos Inc. Related Articles. More articles issued by Allakos Inc. More...
Allakos Announces Results from a Phase 1 Study of ...
Oct 26, 2020 · To participate by telephone, please dial 877-407-9039 (domestic) or 201-689-8470 (international). The conference ID number is 13712474. A live and archived audio...
Allakos | NEA | New Enterprise Associates
Biotechnology company developing antibodies targeting receptors that modulate the activity of immune effector cells involved in inflammation and tissue damage.
Allakos - Oregon Gut Club
Allakos is a biotechnology company developing therapeutic antibodies for inflammatory diseases with significant unmet medical needs. Our lead program is lirentelimab (AK002), an...
Allakos Inc - Company Profile and News - Bloomberg Markets
Allakos Inc. operates as a clinical stage bio-technology company. The Company discovers and develops therapeutic antibodies for the treatment of allergic, inflammatory, and...
Allakos Announces Pricing of Public Offering of Common ...
Oct 28, 2020 · Press Release Allakos Announces Pricing of Public Offering of Common Stock Published: Oct. 28, 2020 at 8:20 p.m. ET
Allakos Announces Presentation from its Eosinophilic ...
Nov 02, 2020 · Allakos is a clinical stage biotechnology company developing antibodies that target immunomodulatory receptors present on immune effector cells involved in...
Allakos Announces the Initiation of Antolimab (AK002 ...
Mar 24, 2020 · The conference ID number is 13700828. A live and archived audio webcast can be accessed through the Investors section of the Company's website at www.allakos.com....
Page Resources Breakdown
Homepage Links Analysis
Website Inpage Analysis
| H1 Headings: | Not Applicable | H2 Headings: | Not Applicable |
| H3 Headings: | Not Applicable | H4 Headings: | Not Applicable |
| H5 Headings: | Not Applicable | H6 Headings: | Not Applicable |
| Total IFRAMEs: | Not Applicable | Total Images: | 1 |
| Google Adsense: | Not Applicable | Google Analytics: | UA-114980669-1 |
Websites Hosted on Same IP (i.e. 69.63.140.80)
Frontotemporal dementia | The Bluefield Project to Cure FTD
The Bluefield Project was established in 2010 to fund research directed towards curing frontotemporal dementia (FTD). FTD is a devastating, early-onset degenerative brain...
9,164,816 
$ 240.00
HTTP Header Analysis
Status-Code: 200
Status: 200 OK
Date: Mon, 23 Sep 2019 03:46:42 GMT
Server: Apache
X-Frame-Options: SAMEORIGIN
Vary: User-Agent,Accept-Encoding
Last-Modified: Sat, 21 Sep 2019 01:19:45 GMT
Cache-Control: max-age=30, s-maxage=30
Expires: Mon, 23 Sep 2019 03:47:12 GMT
X-hccms: hit
Content-Encoding: gzip
Content-Length: 1954
Content-Type: text/html;charset=UTF-8
Domain Information
| Domain Registrar: |
NameCheap, Inc.
|
|---|---|
| Registration Date: | 2012-05-09 1 decade 2 years 4 months ago |
| Last Modified: | 2018-02-12 6 years 7 months 1 week ago |
Domain Nameserver Information
| Host | IP Address | Country | |
|---|---|---|---|
| ns1.asmallorange.com | |
162.214.130.225 | United States |
| ns2.asmallorange.com | |
162.214.130.228 | United States |
DNS Record Analysis
| Host | Type | TTL | Extra |
|---|---|---|---|
| allakos.com | A | 14386 |
IP: 69.63.140.80 |
| allakos.com | NS | 86400 |
Target: ns2.asmallorange.com |
| allakos.com | NS | 86400 |
Target: ns1.asmallorange.com |
| allakos.com | SOA | 86400 |
MNAME: ns1.asmallorange.com RNAME: root.localhost.localdomain Serial: 2019071603 Refresh: 86400 Retry: 7200 Expire: 3600000 |
| allakos.com | MX | 14400 |
Target: allakos-com.mail.protection.outlook.com |
| allakos.com | TXT | 14400 |
TXT: ivdm84f266ohao15djmmdmse1s |
| allakos.com | TXT | 14400 |
TXT: MS=ms48889298 |
| allakos.com | TXT | 14400 |
TXT: v=spf1 ip4:104.129.192.94 include:spf.protection.outlook.com include:email.freshservice.com -all |
| allakos.com | SRV | 3600 |
Priority: 100 Target: sipdir.online.lync.com Weight: 1 Port: 443 |
Top Organic Keyword
| 1. | allakos |
| 2. | allakos inc |
| 3. | ak002 |
| 4. | allakos earnings |
| 5. | allakos, inc. |
Top Paid Keyword
| Not Applicable |
Full WHOIS Lookup
Registry Domain ID:
1719008346_DOMAIN_COM-VRSN
Registrar WHOIS Server:
whois.namecheap.com
Registrar URL:
http://www.namecheap.com
Updated Date:
2018-02-12T03:03:03Z
Creation Date:
2012-05-08T21:12:27Z
Registry Expiry Date:
2026-05-08T21:12:27Z
Registrar: NameCheap, Inc.
Registrar IANA
ID: 1068
Registrar Abuse Contact Email:
[email protected]
Registrar Abuse Contact Phone:
+1.6613102107
Domain Status: clientTransferProhibited
https://icann.org/epp#clientTransferProhibited
Name Server:
NS1.ASMALLORANGE.COM
Name Server: NS2.ASMALLORANGE.COM
DNSSEC:
unsigned
URL of the ICANN Whois Inaccuracy Complaint Form:
https://www.icann.org/wicf/
>>> Last update of whois database:
2019-09-23T03:46:44Z
Similarly Ranked Websites
·¹Àú½Å¹®
°ñÇÁ, ·¹Àú ÁÖ°£Áö, °ñÇÁÀå, ȸ¿ø±Ç, ¿ëÇ°, °æ±â, ·¹Àú Á¤º¸ ¼ö·Ï.
2,037,825 $ 720.00
ARMA3.RU - Русскоязычное Arma 3 сообщество - АРМА3.РУ
Официальное сообщество ArmA 3, последние новости по игре ArmA 3, новости разработки, моды, аддоны, дополнения, обновления для ArmA 3. Купить ArmA 3.
2,037,827 $ 720.00
COE1 Anna University Updates 2020, coe2.annauniv.edu &...
coe1.annauniv.edu , coe1 result, coe2 result, coe1.annauniv.edu result, aucoe result,anna university announcements, nov dec 2020 results, aucoe
2,037,851 $ 720.00